Articles On Polynovo (ASX:PNV)

Summary Azure (ASX:AZS) starts gold exploration at Kookynie PolyNovo (ASX:PNV) jumps on increasing revenue momentum Incitec Pivot (ASX:IPL) changes manufacturing model, shares surge on ASX  The S&P/ASX200 is up today, gainin...

At lunch on Tuesday, the S&P/ASX 200 Index (ASX: XJO) has followed the lead of US markets and is pushing higher. The benchmark index is currently up 0.5% to 7,370.5 points. Here’s what is happening on the ASX 200 today: Nearmap share p...

In late morning trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record another solid gain. At the time of writing, the benchmark index is up 0.5% to 7,368.5 points. Four ASX shares that are climbing more than most today are lis...

The PolyNovo Ltd (ASX: PNV) share price is charging higher on Tuesday morning. In early trade, the medical device company’s shares are up 8% to $2.57. Why is the PolyNovo share price charging higher? The catalyst for the rise in the PolyNo...

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

Summary  The S&P/ASX200 ended 24.20 points or 0.33% lower at 7,290. The index declined over 1% to hit an intraday low of 7,261. The market sentiments were dented after the RBA announced the plan to tweak its quantitative easing to...

Summary The S&P/ASX200 traded up by 12.60 points or 0.17% at 7,327.60 by Tuesday afternoon. All the “big four” banks were trading higher ahead of the monetary policy announcement by the Reserve Bank. The energy sector was the best...

Summary The ASX 200 ends 27.20 points or 0.37% lower at 7,359. Seven out of 11 sectors ended in red, while telecom and energy emerging as the worst performer. The market sentiment was dented as US Federal Reserve indicated a rate hike...

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

Polynovo Ltd (ASX: PNV) had a tough May. Shares in the medical company were trading around $3.05 at the start of the month only to drop almost 15% to $2.60.  The Polynovo share price is trading at $2.59 at the time of writing. The jewel in...

Shares in medical device manufacturer Polynovo Ltd (ASX: PNV) have been on a bit of a rollercoaster recently and are down 20% in the last six weeks. Polynovo’s shares reached a record high of over $4 late last year, giving it a market capit...

Summary The ASX 200 closed lower by 19 points or 0.27% at 7142.60. The Australian dollar and bond yields rise after the RBA policy decision. The RBA kept interest rates steady at record lows to support the economic growth. Austral...

Summary The S&P/ASX200 traded lower by 60 points or 0.44% at 7130, after setting a new 52-week high in the previous session. Nine of 11 sectors trade in the red, with financials being the worst performer having shed 0.95%. Tech co...

This morning, medical device developer Avita Medical Inc (ASX: AVH) released its Q3 FY21 results to the market. Avita’s shares are up 2.9% at the time of writing. While many ASX companies saw a V-shaped recovery coming out of COVID-19, Avit...

Summary The benchmark index ASX 200 trades higher by 69.1 points or 0.98% at 7149 at the close. Materials index was top performing sector, up over 3% on the back of rise in commodity prices. The top 5 performing stock on the ASX are P...

Summary The benchmark index ASX 200 gains 84 points or 1.19% to 7164, hitting its fresh 14-month high. Eight of 11 sectors traded in green, while Materials was the best performing sector, gaining 2.5%. The share price of A2 Milk dropp...

The benchmark index ASX 200 extended loss by the close, led by sharp selling in technology stocks. The tech stocks dropped, taking weak cues from NASDAQ which fell nearly 2% in the overnight trade. The ASX 200 was trailing by 44 points or...

After opening higher on Thursday, the ASX 200 dipped due to losses in banking and technology stocks. The tech stocks dipped after NASDAQ fell nearly 2% in the overnight trade. However, miners rose to their highest in nearly 13 years. The gl...

Summary Snapping three session gaining streak, ASX200 was trading lower on Thursday. The benchmark index was down 31 points to trade at 7064, retreating from its 52-week high. 9 of 11 sectors were trading in red, while information tec...

On 5th May 2021, ASX 200 witnessed a rise and it managed to make a new 100-day high. Notably, ASX 200 gained 27.90 points or 0.39% to 7,095.80. As the below table depicts, ASX 300 encountered a rise of 0.36% to 7,088.10 and ASX 200 rose by...

Summary The ASX 200 crosses 7100 mark, its 14-month highest level since the coronavirus pandemic-led sell-off triggered in February last year. The market witnessed broad-based rally, with nine of 11 sectors trading in green. Nearmap s...

Summary After a gap of more than a year, the S&P/ASX 200 Index reclaimed 7,100 points on Wednesday, its highest level since the COVID-19 pandemic-led sell-off triggered in February and March last year. Six of 11 sectors were tradin...

Source:everything possible, Shutterstock Summary Oceania Healthcare Ltd announced that it non-written retail offer has closed oversubscribed. The company received applications totaling nearly 50 million for NZ$50 million for its NZ$20...

Source: Sittipong Phokawattana, Shutterstock Summary The ASX 200 traded higher today on the back of gold and technology stocks, which were driven by a rise in inflation and a drop in borrowing costs. The gold stockswere in demand on a...

The most intriguing big buy from a director last week came for forensic data company Nuix (ASX:NXL). Nuix was one of last year’s biggest IPOs and nearly doubled in the few weeks after its debut but then retreated in February after missing p...

The S&P/ASX 200 Index (ASX: XJO) was on form again in March and recorded a solid 1.8% gain to finish at 6,790.7 points. While a good number of shares pushed higher with the market, some climbed more than most. Here’s why these were the...

Big brokers have run the ruler over the ASX 200 shares they believe have the tailwinds and fundamentals to outperform the market. These 4 ASX shares were rated as a buy or buy-equivalent on Monday 29 March.  Amcor CDI (ASX: AMC)  Amcor is...

World Overnight SPI Overnight (Jun) 6804.00 + 44.00 0.65% S&P ASX 200 6799.50 – 24.70 – 0.36% S&P500 3971.09 – 3.45 – 0.09% Nasdaq Comp 13059.65 – 79.08 – 0.60% DJIA 33171.37 + 98.49 0.30% S&P500 VIX 20.74 + 1.88 9...

Source:Shahril KHMD, Shutterstock Summary The Australian benchmark equity index ASX 200 on Monday opened higher after major indices on Wall Street rallied on hopes of strong economic recovery. Bluescope Steel (ASX:BSL), Austal (ASX:AS...

Source: katjen, Shutterstock On Friday, the market opened flat and gained points towards lunchtime. The benchmark index ASX 200 maintained the momentum and, towards the end, added 33.60 points and traded at 6824.20 points, up by 0.49% on t...

Medical device manufacturer PolyNovo Ltd (ASX: PNV) has had an impressive run recently, with its share price up nearly 30% in just two weeks. A positive announcement yesterday gave Polynovo’s share price an additional 5% boost. PolyNovo’s f...

Copyright © 2021 Kalkine Media Pty Ltd. On 25th March 2021, the equity market of Australia settled in green as ASX 200 surged by 0.17% to 6790.60. On the same day, Academic & Educational Services sector and Healthcare sector rose by 1....

Big brokers have run the ruler on new announcements and notable share price movements. Here are the ASX 200 shares that have been upgraded to a buy or buy equivalent rating on Thursday.  4 bullish ASX 200 shares  Bapcor Ltd (ASX: BAP)  Bap...

The PolyNovo Ltd’s (ASX: PNV) share price took flight this afternoon after it announced an agreement with a US group purchasing organisation (GPO), Premier Inc. The medical device company will sell its novel range of bio-resorbable polymer...

Source:THICHA SATAPITANON, Shutterstock Summary ASX 200 lost the momentum after a marginal gain during the afternoon. Health care performed the best during intraday, and IT remained the worst performing sector. The benchmark index...

Source: solarseven, Shutterstock After the initial loses, the market tried hard to gain points amid a volatile trading session, and towards the end, it traded in the positive territory. The benchmark index ASX 200 settled at 6752.50 points...

Source: mstanley, Shutterstock On Friday, the market opened lower however, the bulls managed to push the market from the lows to an extent up to the lunch session. However, the selling pressure seeped in and the market declined  towards th...

Source: BEST-BACKGROUNDS,Shutterstock On Friday, as expected market continues the downturn trend. The benchmark index ASX 200 continues losing points, and by lunch, it lost 11.50 points and traded at 6734.40 points, a decline of 0.17% on t...

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

Source: Guschenkova, Shutterstock Summary Healthcare companies are attracting increasing attention from investors as many of these have received regulatory approvals for making corona drugs. Medical device maker Polynovo Ltd has been...

Copyright © 2021 Kalkine Media Pty Ltd. On 16th March 2021, the equity market of Australia settled in green as ASX 200 surged by 0.80% to 6827.10. On the same day, academic & educational services sector and healthcare sector rose by 3....

Source: Feylite, Shutterstock Summary Australian equity markets saw a broad-based rally on Tuesday as bond yields fell. Information technology, real estate, healthcare, and cyclicals were strong during the trading session. Austral...

ASX medical shares reported some positive results in the most recent reporting round. The medical sector is a popular choice for both growth and income investors. More mature shares such as Cochlear Limited (ASX: COH) and Fisher & Pay...

The PolyNovo Ltd (ASX: PNV) share price has been attracting attention since the company announced a Nordic expansion last week. On 24 February 2021, the PolyNovo trading volume jumped 26% higher than its usual daily average, sending shares...

The PolyNovo Ltd (ASX: PNV) share price is climbing higher in the early afternoon trade. This comes after the company announced that it will expand its presence into new geographical markets. At the time of writing, the medical device comp...

Source: Shutterstock Summary Medical device developer PolyNovo witnessed increased revenue from NovoSorb BTM sales in all direct markets. PolyNovo stated that the hernia program has now several prototypes to address the market and reg...

Australian medical device company PolyNovo Ltd (ASX: PNV) has released its first-half result to the market. At the time of writing, the PolyNovo share price remains effectively unchanged at $2.40. Here’s my take on PolyNovo’s results. COVID...

Polynovo Ltd (ASX: PNV) shares are swinging around today after the company released its earnings report for the first half of the 2021 financial year (1H21) before market open this morning. At the time of writing, the Polynovo share price...

ASX mid-cap healthcare company Avita Medical Inc (ASX: AVH) released its second-quarter FY21 results to the market last week. Despite recording positive revenue numbers, the Avita share price has continued to slide lower over the last five...

ASX biotech shares have had an up and down start to the year. While the S&P/ASX 200 Index (ASX: XJO) is up 1.8%, shares in Pro Medicus Limited (ASX: PME) and Polynovo Ltd (ASX: PNV) have been far more volatile. Why ASX biotech shares a...